Napoleone Ferrara Selected Research

Napoleone Ferrara Research Topics

Disease

75	Neoplasms (Cancer) 01/2020 - 03/2002
21	Macular Degeneration (Age-Related Maculopathy) 01/2016 - 12/2002
11	Pathologic Neovascularization 01/2016 - 12/2002
11	Hypoxia (Hypoxemia) 02/2013 - 01/2002
10	Carcinogenesis 01/2020 - 03/2002
8	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2009
6	Inflammation (Inflammations) 01/2020 - 11/2004
6	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 06/2004
5	Choroidal Neovascularization 08/2013 - 11/2005
4	Infertility (Sterility) 01/2018 - 03/2004
3	Ovarian Neoplasms (Ovarian Cancer) 11/2017 - 11/2002
3	Ischemia 05/2014 - 04/2010
3	Ascites 11/2006 - 11/2002
2	Pain (Aches) 01/2018 - 06/2015
2	Cognitive Dysfunction 08/2016 - 05/2016
2	Obesity 08/2016 - 05/2016
2	Hyperglycemia 02/2015 - 01/2014
2	Disease Progression 02/2010 - 06/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2007 - 02/2007
2	Carcinoma (Carcinomatosis) 05/2006 - 11/2002
2	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2005 - 08/2004
2	Neointima 10/2004 - 01/2002
1	Geographic Atrophy 11/2022
1	Retinal Neovascularization 12/2020
1	Colitis 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Eye Diseases (Eye Disease) 01/2019
1	Breast Neoplasms (Breast Cancer) 10/2018
1	Kallmann Syndrome (Kallmann's Syndrome) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 05/2016
1	Neuroinflammatory Diseases 05/2016
1	Glioma (Gliomas) 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Cancer Pain 06/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2014
1	Prostatic Neoplasms (Prostate Cancer) 07/2013
1	Blindness (Hysterical Blindness) 06/2013

Drug/Important Bio-Agent (IBA)

87	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2002
18	Monoclonal AntibodiesIBA 01/2016 - 11/2002
17	Bevacizumab (Avastin)FDA Link 11/2017 - 12/2002
15	AntibodiesIBA 01/2018 - 07/2004
7	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 07/2008
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2004
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 01/2004
6	Angiogenesis InhibitorsIBA 01/2016 - 07/2004
5	LigandsIBA 06/2015 - 03/2002
4	MitogensIBA 11/2022 - 05/2006
4	Protein Isoforms (Isoforms)IBA 01/2020 - 03/2003
4	Pharmaceutical PreparationsIBA 01/2020 - 07/2004
4	Blocking AntibodiesIBA 01/2020 - 01/2006
4	Neutralizing AntibodiesIBA 01/2019 - 01/2009
4	Retinaldehyde (Retinal)IBA 01/2016 - 07/2010
4	Transcription Factors (Transcription Factor)IBA 02/2009 - 03/2003
3	CytokinesIBA 01/2019 - 04/2009
3	Biomarkers (Surrogate Marker)IBA 11/2017 - 11/2009
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2015 - 07/2002
3	platelet-derived growth factor C (PDGF-C)IBA 02/2015 - 01/2009
3	Endocrine-Gland-Derived Vascular Endothelial Growth Factor (Vascular Endothelial Growth Factor, Endocrine Gland Derived)IBA 08/2004 - 06/2003
2	IronIBA 01/2020 - 10/2018
2	Conditioned Culture MediaIBA 10/2018 - 05/2006
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2018 - 04/2009
2	Biological ProductsIBA 01/2018 - 05/2011
2	Glucose (Dextrose)FDA LinkGeneric 08/2016 - 05/2016
2	Ranibizumab (Lucentis)FDA Link 01/2016 - 10/2006
2	Neuropilin-1IBA 02/2013 - 01/2010
2	Sunitinib (Sutent)FDA Link 08/2012 - 08/2012
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 07/2011 - 04/2010
2	Immunoglobulin G (IgG)IBA 04/2010 - 07/2004
2	Placenta Growth FactorIBA 04/2010 - 04/2009
2	AntigensIBA 10/2006 - 08/2004
2	Chemotactic FactorsIBA 05/2006 - 07/2004
2	platelet-derived growth factor AIBA 05/2006 - 07/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2005 - 11/2002
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 08/2004 - 08/2003
2	Fluorouracil (Carac)FDA LinkGeneric 07/2004 - 06/2004
1	tipifarnib (R115777)IBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	Iron-Binding ProteinsIBA 01/2020
1	Interleukin-22 (IL-22)IBA 01/2019
1	Transferrin (beta 2 Transferrin)IBA 10/2018
1	Janus KinasesIBA 10/2018
1	Transferrin Receptors (Transferrin Receptor)IBA 10/2018
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018
1	pegaptanib (Macugen)FDA Link 01/2016
1	Vascular Endothelial Growth Factor BIBA 06/2015
1	Streptozocin (Streptozotocin)FDA Link 05/2014
1	AntioxidantsIBA 01/2014
1	Therapeutic UsesIBA 09/2013
1	Interleukin-17 ReceptorsIBA 09/2013
1	Interleukin-17 (Interleukin 17)IBA 09/2013
1	Phosphotransferases (Kinase)IBA 09/2013
1	TOR Serine-Threonine KinasesIBA 07/2013
1	MTOR InhibitorsIBA 07/2013

Therapy/Procedure

40	Therapeutics 01/2020 - 11/2002
7	Drug Therapy (Chemotherapy) 06/2007 - 01/2004
4	Lasers (Laser) 08/2013 - 02/2008
2	Radiotherapy 02/2005 - 01/2004
1	Intraocular Injections 12/2020
1	Immunotherapy 01/2019